Oncology

News

Novartis closes on EU approval for breast cancer drug Piqray

Novartis has moved nearer to claiming approval for its PI3K inhibitor Piqray for breast cancer in the EU, one of a crop of new drugs that the company thinks have blockbuster sa

Oncology

ASCO 2020 virtual annual meeting - day 2

Our live coverage from this year’s slimmed down, virtual version of the American Society of Clinical Oncology (ASCO) annual meeting continues at 8am (ET) as we move into day 2 of the oncolo

Oncology

ASCO 2020 virtual annual meeting - day 1

Our live coverage from this year’s slimmed down, virtual version of the American Society of Clinical Oncology (ASCO) annual meeting begins at 8am (ET).

News

AstraZeneca's (AZ) Tagrisso (osimertinib)

Given after surgery, AZ’s Tagrisso prevents lung cancer comi...

AstraZeneca opened its account at this year’ virtual ASCO meeting with data showing that adjuvant (post-surgery) use of Tagrisso delays the recurrence of EGFR-positive non-smal

News

Merck & Co's Keytruda outperforms chemo in MSI-High colorect...

Merck & Co’s Keytruda (pembrolizumab) immunotherapy has outperformed standard of care in untreated colorectal cancer with certain mutations, offering patients a single-agent therapy opt

News

Roche signs up with Oncimmune to explore immunotherapy respo...

Roche has doubled down on a partnership with UK biotech Oncimmune looking at how autoantibodies can affect patients’ clinical response to cancer immunotherapies.

Novartis closes on EU approval for breast cancer drug Piqray

ASCO 2020 virtual annual meeting - day 2

ASCO 2020 virtual annual meeting - day 1

Given after surgery, AZ’s Tagrisso prevents lung cancer comi...

Merck & Co's Keytruda outperforms chemo in MSI-High colorect...

Roche signs up with Oncimmune to explore immunotherapy respo...

FDA relents and will review Moderna's flu shot

How to meet your physicians where they are online

Oncology

Editor's Picks